A personalized monitoring strategy that integrates clinical assessment, imaging and fluid biomarkers holds the greatest promise for improving the detection of subclinical disease activity, refining risk stratification, and enabling more informed and individualized treatment decisions in contemporary MS care.
Building similarity graph...
Analyzing shared references across papers
Loading...
Fabian Föttinger
Nik Krajnc
Gabriel Bsteh
Current Opinion in Neurology
Medical University of Vienna
Building similarity graph...
Analyzing shared references across papers
Loading...
Föttinger et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d896046c1944d70ce072cf — DOI: https://doi.org/10.1097/wco.0000000000001493